After a long and difficult journey, I finally published the book I set out to write as my legacy, overcoming cancer and the ...

Dr. Ritu Salani shared her advice for patients undergoing advanced treatment options for their cervical cancer who are ...

In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

Brukinsa had a lower risk of disease progression or death versus Imbruvica, as well as a more favorable safety profile, in R/R CLL and SLL.